CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 38 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $290,000 | +14.6% | 16,783 | +17.0% | 0.00% | – |
| Q4 2018 | $253,000 | -51.3% | 14,347 | -50.0% | 0.00% | – |
| Q3 2018 | $520,000 | +48.6% | 28,694 | +60.2% | 0.00% | – |
| Q2 2018 | $350,000 | -10.0% | 17,912 | -45.7% | 0.00% | – |
| Q1 2017 | $389,000 | -13.2% | 32,995 | -3.5% | 0.00% | – |
| Q4 2016 | $448,000 | -12.0% | 34,189 | -2.7% | 0.00% | – |
| Q3 2016 | $509,000 | +20.9% | 35,135 | 0.0% | 0.00% | – |
| Q2 2016 | $421,000 | -30.0% | 35,135 | +9.1% | 0.00% | – |
| Q1 2016 | $601,000 | -13.2% | 32,213 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $692,000 | +34.1% | 32,213 | +5.6% | 0.00% | – |
| Q3 2015 | $516,000 | -27.7% | 30,492 | +60.2% | 0.00% | -100.0% |
| Q2 2015 | $714,000 | – | 19,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| S. MUOIO & CO. LLC | 52,468 | $964,000 | 1.05% |
| Olympiad Research LP | 54,795 | $1,007,000 | 0.58% |
| Alpine Global Management, LLC | 119,902 | $2,204,000 | 0.45% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 65,922 | $1,212,000 | 0.19% |
| First Trust Capital Management L.P. | 32,688 | $601,000 | 0.17% |
| GLAZER CAPITAL, LLC | 232,103 | $4,266,000 | 0.15% |
| Walleye Capital LLC | 105,000 | $1,930,000 | 0.13% |
| Yakira Capital Management, Inc. | 17,588 | $323,000 | 0.08% |
| Dynamic Technology Lab Private Ltd | 17,929 | $330,000 | 0.05% |
| EQUITEC PROPRIETARY MARKETS, LLC | 10,600 | $195,000 | 0.05% |